https://theprint.in/health/all-about-indias-1st-living-drug-that-uses-patients-own-genetically-engineered-cells-to-fight-cancer/1805864/
0
0
10/16/23 at 11:57am
Organization
ThePrint
Author
Sumi Sukanya Dutta
Patients already registering for CAR T-cell therapy, developed indigenously by ImmunoACT under the name NexCAR19. It will be used to treat leukemia & refractory or relapsed lymphoma.
Create an account
or login to join the discussion